Human Genome Sciences, Inc. v. Amgen, Inc.
District Court, D. Delaware
1Opinion of the Court
MEMORANDUM OPINION
SUE L. ROBINSON, District Judge.
I. INTRODUCTION
Plaintiff Human Genome Sciences, Inc. (“HGS”) filed the present action against Immunex Corp. (“Immunex”) and Amgen, Inc. (collectively, “defendants”) on November 30, 2007, seeking review of a Decision on Motions entered on July 26, 2007 and Final Judgment entered November 20, 2007 by the Board of Patent Appeals and Interferences (the “Board”) of the United States Patent and Trademark Office (“PTO”) in Interference No. 105,240 (“the '240 interference”). (D.I.l) Defendants filed a motion to dismiss on January 16, 2008. (D.I.8) For…
2Cases cited12 opinions
- Bell Atlantic Corp. v. TwomblySupreme Court of the United States · 2007
- Erickson v. PardusSupreme Court of the United States · 2007
- Conley v. GibsonSupreme Court of the United States · 1957
- Christopher v. HarburySupreme Court of the United States · 2002
- United States v. James C. DunkelCourt of Appeals for the Seventh Circuit · 1991
7 more not listed; retrieve them via the Exa API.
3Cited by3 opinions
- Abbott GmbH & Co. v. Centocor Ortho Biotech, Inc.District Court, D. Massachusetts · 2012
- Loughlin v. LingCourt of Appeals for the Federal Circuit · 2012
- Human Genome Sciences, Inc. v. Genentech, Inc.District Court, D. Delaware · 2008